These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37614534)

  • 1. Identifying
    Chen LC; Huang WC; Peng KY; Chen YY; Li SC; Syed Mohammed Nazri SK; Lin YH; Lin LY; Lu TM; Kim JH; Azizan EA; Hu J; Li Q; Chueh JS; Wu VC;
    JACC Asia; 2023 Aug; 3(4):664-675. PubMed ID: 37614534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
    Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
    J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
    Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
    Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.
    Eisenhofer G; Durán C; Cannistraci CV; Peitzsch M; Williams TA; Riester A; Burrello J; Buffolo F; Prejbisz A; Beuschlein F; Januszewicz A; Mulatero P; Lenders JWM; Reincke M
    JAMA Netw Open; 2020 Sep; 3(9):e2016209. PubMed ID: 32990741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
    Lee BC; Kang VJ; Pan CT; Huang JZ; Lin YL; Chang YY; Tsai CH; Chou CH; Chen ZW; Liao CW; Chiu YW; Wu VC; Hung CS; Chang CC; Lin YH
    Front Endocrinol (Lausanne); 2022; 13():830130. PubMed ID: 35311227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
    Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
    J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
    Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
    Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
    Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.
    Chang CH; Hu YH; Tsai YC; Wu CH; Wang SM; Lin LY; Lin YH; Satoh F; Wu KD; Wu VC
    Oncotarget; 2017 May; 8(18):29984-29995. PubMed ID: 28415786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and metabolic characters of
    Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
    Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chang YY; Pan CT; Chen ZW; Tsai CH; Peng SY; Chang CC; Lee BC; Liao CW; Peng KY; Chiu YW; Chou CH; Wu VC; Liu LD; Hung CS; Lin YH
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism caused by a pI157S somatic
    Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
    Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
    Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
    J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
    Arnesen T; Glomnes N; Strømsøy S; Knappskog S; Heie A; Akslen LA; Grytaas M; Varhaug JE; Gimm O; Brauckhoff M
    Langenbecks Arch Surg; 2013 Aug; 398(6):869-74. PubMed ID: 23778974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict
    Lu CC; Yen RF; Peng KY; Huang JY; Wu KD; Chueh JS; Lin WY
    Front Endocrinol (Lausanne); 2021; 12():644927. PubMed ID: 33995277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Translationality of
    Kitamoto T; Nishikawa T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.